查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912800

塑膠採血管市場按管型、添加劑類型、填充容量、最終用戶和應用分類－全球預測（2026-2032 年）

Plastic Blood Collection Tubes Market by Tube Type, Additive Type, Fill Volume, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，塑膠採血管市場價值將達到 15.2 億美元，到 2026 年將成長至 15.9 億美元，到 2032 年將達到 26.5 億美元，年複合成長率為 8.26%。

關鍵市場統計數據
基準年 2025 15.2億美元
預計年份：2026年 15.9億美元
預測年份 2032 26.5億美元
複合年成長率 (%) 8.26%

本文全面概述了材料創新、臨床工作流程需求和監管壓力如何重新定義塑膠採血管的優先事項。

血液採集耗材市場正處於一個轉折點，臨床需求、材料科學和監管的交匯正在重塑採購、生產和檢查室運作。塑膠採血管已成為診斷流程中不可或缺的一部分，將即時照護現場與高通量分析平台連接起來。隨著醫療服務模式的演變，這些簡單易用的單次使用產品正對分析前品質、下游偵測可靠性和檢查室整體效率產生深遠影響。

深入分析技術、營運和永續性力量的融合，這將從根本上改變血液採集管的生產和採購。

技術創新、永續性需求以及不斷發展的臨床實踐正在推動多項變革，重塑塑膠採血管的競爭格局和營運模式。首先，材料創新正在加速。製造商正採用先進的聚合物和多層結構來改善阻隔性能並減少萃取物，直接解決分析物穩定性和檢測干擾方面的問題。同時，瓶塞和瓶蓋技術也在不斷改進，以減少溶血、增強真空保持能力並提高自動化相容性。

深入分析 2025 年美國關稅調整如何重塑血液採集管供應鏈的採購、生產決策與採購策略。

2025年起實施的醫療耗材關稅修訂措施，為塑膠採血管價值鏈上的相關人員帶來了新的挑戰。關稅分類和稅率的變化直接影響籌資策略，迫使醫療服務提供者和經銷商重新評估供應商組成和總到岸成本。為此，許多機構正在加速討論供應商多元化、近岸外包以及多源採購協議等方案，以減少對單一國家出口的依賴。

透過全面的細分主導分析，將軟管類型、輔料化學成分、填充量、終端用戶特徵和臨床應用轉化為策略性的產品和商業性行動。

有效的市場區隔分析需要將技術差異轉化為可行的產品、臨床和商業策略。基於採血管類型的市場分析區分了微量採血管、非真空採血管和真空採血管，每種類型都針對不同的採血點和自動化需求。微量採血管可最大限度地減少患者的採血量，廣泛應用於小兒科和門診醫療機構。非真空採血管常用於手動或照護現場檢測 (POC)，而真空採血管則支持高通量檢查室所需的標準化採血量。基於賦形劑類型的產品定位涵蓋檸檬酸鹽、EDTA、肝素、不飽和脂肪酸和草酸鹽。 EDTA 進一步細分為 K2 EDTA 和 K3 EDTA，肝素則分為鋰肝素和鈉肝素。這使得採血管的化學成分能夠與檢測要求和穩定性特徵進行精確匹配。根據填充量進行分類，考慮了臨床工作流程和設備相容性，提供 2-5 mL、<2 mL 和 >5 mL 三種規格。 2-5 mL 規格再細分為 2-3 mL 和 3-5 mL，分別對應兒童、常規診斷和特殊採集通訊協定。最終使用者分類包括血庫、診斷檢查室、醫院和研究機構，每種機構的採購和產品開發重點各不相同。醫院又細分為私立和公立醫院，它們的採購週期、合規制度和創新採納率也各不相同。根據應用領域，臨床專科包括生物化學、血液學、分子診斷學和血清學。生物化學又細分為腎功能檢查和肝功能檢查，血液學則分為全血球計數 (CBC) 和白血球分類計數 (WBC)。這些基於應用領域的區分會影響添加劑的選擇、試管材質要求和標籤需求。

策略區域分析揭示了採購慣例、法規環境和製造重點方面的差異如何影響各個區域的商業機會。

區域趨勢持續影響著製造商、經銷商和醫療保健採購者的優先事項。在美洲，綜合醫療保健系統和大規模國家實驗室對自動化相容性、批次級可追溯性和嚴格品質框架的遵守情況尤為重視，因此對市場需求產生了顯著影響。這為差異化的管材規格和配套服務創造了機遇，包括為採購部門和監管負責人提供檢驗支援和文件包。

深入檢驗血液採集管產業領導者的競爭優勢、契約製造的角色以及創新路徑

老牌製造商、專業加工商和新興參與企業之間的競爭，取決於它們是否能在品質、成本和創新之間取得平衡。主要企業透過投資聚合物科學、添加劑相容性測試以及自動化生產線來確保管材幾何形狀的一致性和真空完整性，從而脫穎而出。與試劑和設備供應商建立策略合作夥伴關係，透過確保檢體處理生態系統的端到端檢驗並降低檢查室實施的複雜性，進一步增強了其價值提案。

為製造商和供應商提供切實可行的、優先考慮的建議，以透過有針對性的投資和夥伴關係來提高產品可靠性、供應彈性和客戶接受度。

產業領導者應制定切實可行的行動計劃，將產品開發、供應鏈韌性和客戶參與相結合，以創造價值並降低風險。首先，應優先投資於檢驗的原料和輔料科學，這些原料和輔料科學能夠提高分析物穩定性並降低檢測干擾，並以可靠的臨床性能數據支持這些結論。其次，應實現製造地和物流合作夥伴的多元化，以平衡成本和前置作業時間，同時降低關稅風險和對單一供應來源的依賴。

一項穩健的混合調查方法，結合了關鍵相關人員訪談、二手文獻檢驗和資料三角驗證，確保了研究結果的可操作性和臨床相關性。

本研究採用混合方法，結合與關鍵相關人員的直接對話、嚴謹的二次檢驗和資料三角測量，以確保研究結果的可信度和可操作性。主要研究包括對各類最終使用者進行結構化訪談，這些最終使用者包括實驗室主任、採購人員、臨床科學家和血庫經理。此外，還與製造商和合約處理商的產品開發和營運負責人進行了技術討論。這些討論主要圍繞著分析前挑戰、產品推廣促進因素、採購標準以及當前產品供應中存在的不足。

最後，一項綜合分析重點闡述如何透過優先考慮產品完整性、監管準備和供應鏈彈性來確保診斷領域的臨床信心和業務連續性。

總之，塑膠採血管是診斷生態系中一個不起眼卻至關重要的組成部分，其設計和化學成分的微小改進就能顯著提升檢體品質、檢查室效率和臨床可靠性。材料創新、監管要求和供應鏈複雜性之間的交匯點，需要製造商、經銷商和臨床用戶協同應對。透過將產品開發與不同臨床應用的具體需求相匹配，並投資於穩健的生產和分銷策略，相關人員可以將技術優勢轉化為可衡量的營運和臨床成果。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按管型分類的塑膠採血管市場

  • 微型採血管
  • 非真空管
  • 真空採血管

9. 依添加劑類型分類的塑膠採血管市場

  • 檸檬酸鹽
  • EDTA
    • K2 EDTA
    • K3 EDTA
  • 肝素
    • 鋰肝素
    • 肝素鈉
  • 不含添加劑
  • 草酸鹽

第10章 依填充量分類的塑膠採血管市場

  • 2～5 ml
    • 2～3 ml
    • 3～5 ml
  • 少於2毫升
  • 超過5毫升

第11章 依最終用戶分類的塑膠採血管市場

  • 血庫
  • 診斷檢查室
  • 醫院
    • 私人的
    • 公共機構
  • 研究所

第12章：按應用分類的塑膠採血管市場

  • 生物化學
    • 腎功能
    • 肝功能
  • 血液學
    • CBC
    • 白血球分類
  • 分子診斷
  • 血清學

第13章：各地區塑膠採血管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 塑膠採血管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國塑膠採血管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國塑膠採血管市場

第17章：中國塑膠採血管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ADMA Biologics, Inc.
  • Bharat Serums and Vaccines Limited
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Behring AG
  • GC Pharma Corp.
  • Grifols, SA
  • Hualan Biological Engineering Inc.
  • Kamada Ltd.
  • Kedrion SpA
  • LFB SA
  • Octapharma AG
  • Prothya Biosolutions BV
  • Sanquin Plasma Products BV
  • Takeda Pharmaceutical Company Limited
Product Code: MRR-AE420CB13AA7

The Plastic Blood Collection Tubes Market was valued at USD 1.52 billion in 2025 and is projected to grow to USD 1.59 billion in 2026, with a CAGR of 8.26%, reaching USD 2.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.52 billion
Estimated Year [2026] USD 1.59 billion
Forecast Year [2032] USD 2.65 billion
CAGR (%) 8.26%

Comprehensive contextual overview of how material innovation, clinical workflow demands, and regulatory pressure are redefining plastic blood collection tube priorities

The landscape of blood collection consumables is at an inflection point where clinical need, material science and regulatory scrutiny converge to reshape procurement, manufacturing and laboratory practice. Plastic blood collection tubes have become foundational components across diagnostic workflows, bridging sample collection at the point of care with high-throughput analytical platforms. As healthcare delivery models evolve, these simple disposables exert outsized influence on pre-analytical quality, downstream test reliability, and overall laboratory efficiency.

This introduction frames the core drivers of change affecting plastic blood collection tubes, including advances in polymer formulations, additive chemistry, and manufacturing scale-up. It also highlights shifting end-user expectations driven by hospitals, diagnostic laboratories, blood banks and research institutes seeking greater consistency, contamination control and traceability. By situating product innovation alongside operational pressures such as supply continuity and compliance requirements, this section sets the scene for a detailed exploration of where value is created and where vulnerabilities persist in the tube ecosystem.

Transitioning from historical supply models to contemporary demands, readers will appreciate how seemingly incremental design choices-tube geometry, stopper composition, and additive selection-cascade into measurable differences in specimen stability and workflow compatibility. This context is essential for executives and product teams aiming to prioritize investments, align with clinical stakeholders, and manage risk across sourcing and quality assurance functions.

Detailed analysis of the converging technological, operational, and sustainability forces that are driving fundamental transformation across blood collection tube manufacturing and procurement

Multiple transformative shifts are redefining the competitive and operational dynamics of plastic blood collection tubes, driven by technological innovation, sustainability imperatives and evolving clinical practice. First, material innovation is accelerating; manufacturers are deploying advanced polymers and multilayer constructions that improve barrier properties and reduce leachables, directly addressing concerns about analyte stability and assay interference. At the same time, stopper and cap technologies are being engineered to reduce hemolysis, enhance vacuum integrity and enable improved automation compatibility.

Second, the convergence of laboratory automation and sample traceability is elevating requirements for tube standardization. As laboratories increase throughput and integrate robotic handling, tube dimensions, barcode legibility and closure reliability are now critical parameters for procurement teams. Third, there is a growing emphasis on single-use contamination control across blood banks and laboratories, with a heightened focus on sterile manufacturing, lot-level traceability and documentation to support regulatory audits.

Fourth, sustainability expectations are prompting manufacturers to explore recycled resins, lightweight designs and take-back programs, while still ensuring compliance with biocompatibility and sterility standards. Finally, supply chain resilience considerations, including nearshoring and diversified supplier bases, are changing sourcing strategies as stakeholders balance cost, lead time and geopolitical risk. These shifts collectively alter the product development roadmap and the procurement calculus for clinical laboratories and health systems.

In-depth exploration of how the 2025 United States tariff adjustments have reshaped sourcing, production decisions, and procurement strategies across the blood collection tube ecosystem

The introduction of revised tariff measures affecting medical consumables in 2025 has introduced a new layer of complexity for stakeholders in the plastic blood collection tube value chain. Changes to tariff classifications and duty rates have had an immediate effect on procurement strategies, prompting healthcare providers and distributors to reassess supplier footprints and total landed cost considerations. In response, many organizations have accelerated discussions around supplier diversification, nearshoring options and multi-sourcing agreements to mitigate dependency on single-country exports.

At the manufacturing level, tariff-related cost pressures have prompted some producers to revisit supply contracts for raw polymer resins and ancillary components, renegotiate logistics terms, and explore tariff engineering-where permissible-to optimize harmonized system classifications. Contract manufacturers and converters facing increased import duties have been compelled to evaluate long-term investments in regional production capacity or to restructure distribution networks to maintain margin and continuity of supply. These adaptations often entail capital allocation trade-offs between capacity expansion and product innovation.

Regulatory and procurement teams have also adjusted contracting timelines and inventory policies to buffer against tariff volatility. Some buyers have increased strategic stockholding for critical SKUs, while others have adopted more dynamic procurement frameworks that incorporate tariff scenario planning into supplier scorecards. In parallel, pricing models for end users have been recalibrated to reflect duty-driven cost increases, with sustained emphasis on justifying premium specifications through demonstrable clinical and operational benefits rather than purely price-based decisions.

Taken together, the 2025 tariff environment has reinforced the strategic importance of supply chain intelligence, legal and customs expertise, and collaborative supplier relationships. Stakeholders who proactively integrate tariff risk into product lifecycle planning and sourcing strategies are better positioned to preserve service levels and protect margins while maintaining compliance with international trade rules.

Comprehensive segmentation-driven insights that translate tube type, additive chemistry, fill volume, end-user characteristics, and clinical application into strategic product and commercial actions

Effective segmentation insight requires translating technical distinctions into actionable product, clinical and commercial strategies. Based on Tube Type, market analysis distinguishes Microcollection Tube, Non Vacuum Tube, and Vacuum Tube, each serving distinct collection points and automation needs: microcollection formats minimize patient draw and are prevalent in pediatric and outpatient settings, non-vacuum tubes are often used for manual or point-of-care procedures, and vacuum tubes support standardized draw volumes for high-throughput laboratories. Based on Additive Type, product positioning spans Citrate, Edta, Heparin, No Additive, and Oxalate, with EDTA subdivided into K2 EDTA and K3 EDTA and Heparin further classified into Lithium Heparin and Sodium Heparin, enabling precise matching of tube chemistry to assay requirements and stability profiles. Based on Fill Volume, clinical workflows and device compatibility are informed by 2-5 mL, less than 2 mL, and greater than 5 mL options, where the 2-5 mL category is further differentiated into 2-3 mL and 3-5 mL increments to align with pediatric, routine diagnostic, and specialty collection protocols. Based on End User, procurement and product development priorities vary across Blood Banks, Diagnostic Laboratories, Hospitals, and Research Institutes, with Hospitals further segmented into Private and Public facilities that have differing buying cycles, compliance frameworks and innovation adoption rates. Based on Application, clinical segmentation encompasses Biochemistry, Hematology, Molecular Diagnostics, and Serology, with Biochemistry subdivided into Kidney Function and Liver Function panels and Hematology separated into CBC and WBC Differential assays; these application-driven distinctions influence additive selection, tube material requirements and labeling needs.

Translating these segmentations into commercial actions means aligning R&D roadmaps to additive and volume requirements, ensuring manufacturing scale and quality systems support both vacuum and microcollection formats, and tailoring go-to-market strategies to the nuanced procurement rhythms of hospitals versus research institutes. Moreover, regulatory submissions and stability studies must be designed with the specific additive chemistry and intended application in mind, since analytical compatibility and specimen integrity are the primary decision levers for clinical end users. Integration between product management, clinical affairs and supply chain teams is therefore critical to capture value across these defined segments.

Strategic regional analysis highlighting how divergent procurement practices, regulatory environments, and manufacturing priorities shape opportunities across global territories

Regional dynamics continue to shape priorities for manufacturers, distributors and healthcare purchasers in divergent ways. In the Americas, demand is strongly influenced by integrated health systems and large national laboratories that prioritize automation compatibility, lot-level traceability and compliance with stringent quality frameworks. This creates opportunities for differentiated tube specifications and bundled service offerings that include validation support and documentation packages aimed at procurement and regulatory reviewers.

In Europe, Middle East & Africa, heterogeneity in procurement mechanisms, regulatory constituencies and healthcare infrastructure drives a broad spectrum of product requirements. Private labs and public health institutions often exhibit distinct adoption curves for advanced tube technologies, while regional harmonization efforts and cross-border trade relationships influence manufacturing and distribution strategies. Manufacturers operating in this region frequently need flexible regulatory dossiers and multilingual technical documentation to support market access.

In the Asia-Pacific region, growth in decentralized testing, expanding clinical trial activity and investments in domestic manufacturing capacity have elevated the importance of scalable production, cost-efficiency and local regulatory registration capabilities. Regional supply chain developments and raw material sourcing dynamics also contribute to divergent lead times and logistics planning. Across all regions, localized service models, technical support and training are increasingly essential differentiators as laboratories seek suppliers who can reduce onboarding friction and ensure consistent pre-analytical performance under varying operational contexts.

Understanding regional nuances enables stakeholders to prioritize channel strategies, invest in targeted regulatory pathways, and design inventory and logistics models that reflect the realities of cross-border trade, tariff exposures and end-user expectations in each geography.

Insightful examination of competitive advantages, contract manufacturing roles, and innovation pathways that determine leadership in the blood collection tube industry

Competitive dynamics among established manufacturers, specialty converters and emerging entrants are driven by the ability to bridge quality, cost and innovation. Leading companies differentiate through investments in polymer science, additive compatibility testing and automated production lines that deliver consistent tube geometry and vacuum integrity. Strategic partnerships with reagent and instrument providers further enhance value propositions by ensuring sample handling ecosystems are validated end-to-end, reducing the complexity for laboratory adoption.

Contract manufacturing organizations and regional converters play a key role in providing flexibility for customers seeking localized supply or private-label solutions. These partners often provide accelerated lead times and the capacity to support customized formulations and labeling, which is particularly valuable for large hospital networks and clinical research organizations requiring tight integration into trial supply chains. Emerging entrants are focusing on sustainability claims, novel polymer blends and enhancements to barcode and closure technologies, seeking to appeal to time-constrained procurement teams and sustainability-minded healthcare systems.

Across this competitive landscape, intellectual property around additive-stopper interactions, validated stability protocols, and manufacturing know-how is increasingly important. Collaboration between clinical affairs, regulatory teams and R&D can shorten time-to-adoption by producing robust validation packages and real-world evidence that demonstrate how specific tube configurations improve analytical performance or operational throughput. Ultimately, companies that align technical differentiation with service-oriented commercial models and robust supply chain guarantees are best positioned to win long-term partnerships with high-volume laboratory customers.

Practical and prioritized recommendations for manufacturers and suppliers to strengthen product reliability, supply resilience, and customer adoption through targeted investments and partnerships

Industry leaders should pursue a pragmatic set of actions that align product development, supply chain resilience and customer engagement to capture value and mitigate risk. First, prioritize investments in validated material and additive science that demonstrably improves analyte stability and reduces assay interference, and ensure these claims are supported by robust clinical performance data. Second, diversify manufacturing footprints and logistics partnerships to reduce exposure to tariff volatility and single-source dependencies while balancing cost and lead time considerations.

Third, develop comprehensive technical support packages and validation toolkits that shorten laboratory onboarding time and provide clear evidence of compatibility with common analyzers and workflows. Fourth, integrate sustainability goals pragmatically by targeting areas where lightweighting, recyclable materials or packaging reductions do not compromise sterility or analytical performance, thereby meeting customer expectations without introducing undue regulatory risk. Fifth, strengthen commercial models by offering flexible supply agreements, private-label options, and tailored inventory solutions that accommodate the procurement rhythms of both public and private hospitals as well as research institutions.

Finally, cultivate cross-functional collaboration between R&D, regulatory affairs, and customer success teams to accelerate adoption and to maintain downstream resilience. By focusing on these coordinated actions, companies can convert technical differentiation into durable customer relationships and operational advantages in a landscape where reliability, compliance and cost-effectiveness remain the central value drivers.

Robust mixed-methods research methodology combining primary stakeholder interviews, secondary literature validation, and data triangulation to ensure actionable and clinically relevant insights

This research employs a mixed-methods approach combining primary stakeholder engagement with rigorous secondary validation and data triangulation to ensure reliability and actionable insight. Primary research included structured interviews with a cross-section of end users, including laboratory directors, procurement leads, clinical scientists and blood bank managers, as well as technical discussions with product development leaders and operations executives from manufacturers and contract converters. These conversations focused on pre-analytical challenges, adoption drivers, procurement criteria, and perceived gaps in current product offerings.

Secondary research drew on publicly available regulatory documentation, peer-reviewed publications on pre-analytical variables and polymer biocompatibility, industry trade and logistics reports, and technical white papers that describe additive performance and stability testing methodologies. Wherever possible, secondary sources were used to corroborate statements from primary interviews and to provide context for regional regulatory nuances and trade developments.

Data synthesis followed a triangulation protocol to reconcile differing perspectives and to identify consistent themes across stakeholder groups. The methodology prioritized clinical relevance and operational impact, ensuring that technical assertions about additive chemistry, fill volumes and endpoint compatibility were grounded in laboratory practice. Limitations of the approach are transparently acknowledged, including potential variability in procurement practices across institutions and the evolving nature of trade policies, and recommendations are framed to be resilient to such variability by emphasizing adaptable strategies and evidence-based validation.

Concluding synthesis highlighting how prioritized product integrity, regulatory readiness, and supply resilience combine to secure clinical trust and operational continuity in diagnostics

In conclusion, plastic blood collection tubes remain an unglamorous yet essential component of the diagnostic ecosystem, where small improvements in design and chemistry can yield outsized benefits in specimen integrity, laboratory throughput and clinical confidence. The intersection of material innovation, regulatory expectations and supply chain complexity demands coordinated responses from manufacturers, distributors and clinical customers alike. By aligning product development with the precise needs of segmented clinical applications and by investing in resilient manufacturing and distribution strategies, stakeholders can convert technical advantages into measurable operational and clinical outcomes.

The evolving tariff environment and regional procurement differences further underscore the need for proactive supply chain intelligence and flexible sourcing. Meanwhile, ongoing integration of automated workflows and the pursuit of sustainability imperatives will continue to shape procurement decisions and product roadmaps. For leaders who prioritize validated performance, regulatory readiness and customer-centric service, there is a clear pathway to strengthen market positioning and to support the broader goals of diagnostic accuracy and patient safety.

Ultimately, the most successful organizations will be those that treat tubes not as commodities but as engineered elements of the diagnostic chain, investing in the evidence, manufacturing rigor and customer partnerships necessary to ensure reliable sample collection and reproducible results across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plastic Blood Collection Tubes Market, by Tube Type

  • 8.1. Microcollection Tube
  • 8.2. Non Vacuum Tube
  • 8.3. Vacuum Tube

9. Plastic Blood Collection Tubes Market, by Additive Type

  • 9.1. Citrate
  • 9.2. Edta
    • 9.2.1. K2 Edta
    • 9.2.2. K3 Edta
  • 9.3. Heparin
    • 9.3.1. Lithium Heparin
    • 9.3.2. Sodium Heparin
  • 9.4. No Additive
  • 9.5. Oxalate

10. Plastic Blood Collection Tubes Market, by Fill Volume

  • 10.1. 2-5 Ml
    • 10.1.1. 2-3 Ml
    • 10.1.2. 3-5 Ml
  • 10.2. <2 Ml
  • 10.3. >5 Ml

11. Plastic Blood Collection Tubes Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals
    • 11.3.1. Private
    • 11.3.2. Public
  • 11.4. Research Institutes

12. Plastic Blood Collection Tubes Market, by Application

  • 12.1. Biochemistry
    • 12.1.1. Kidney Function
    • 12.1.2. Liver Function
  • 12.2. Hematology
    • 12.2.1. Cbc
    • 12.2.2. Wbc Differential
  • 12.3. Molecular Diagnostics
  • 12.4. Serology

13. Plastic Blood Collection Tubes Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Plastic Blood Collection Tubes Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Plastic Blood Collection Tubes Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Plastic Blood Collection Tubes Market

17. China Plastic Blood Collection Tubes Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ADMA Biologics, Inc.
  • 18.6. Bharat Serums and Vaccines Limited
  • 18.7. Biotest AG
  • 18.8. China Biologic Products Holdings, Inc.
  • 18.9. CSL Behring AG
  • 18.10. GC Pharma Corp.
  • 18.11. Grifols, S.A.
  • 18.12. Hualan Biological Engineering Inc.
  • 18.13. Kamada Ltd.
  • 18.14. Kedrion S.p.A.
  • 18.15. LFB S.A.
  • 18.16. Octapharma AG
  • 18.17. Prothya Biosolutions B.V.
  • 18.18. Sanquin Plasma Products B.V.
  • 18.19. Takeda Pharmaceutical Company Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MICROCOLLECTION TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MICROCOLLECTION TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MICROCOLLECTION TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NON VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NON VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NON VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K2 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K2 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K3 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY K3 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LITHIUM HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LITHIUM HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LITHIUM HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SODIUM HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SODIUM HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SODIUM HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NO ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY NO ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY OXALATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY OXALATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY OXALATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-3 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-3 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-3 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 3-5 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 3-5 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 3-5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY <2 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY <2 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY <2 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY >5 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY >5 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY >5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY KIDNEY FUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY KIDNEY FUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY KIDNEY FUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LIVER FUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LIVER FUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY LIVER FUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CBC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CBC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY CBC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY WBC DIFFERENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY WBC DIFFERENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY WBC DIFFERENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 220. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 221. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 222. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 223. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 256. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 257. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 258. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 259. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 268. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 269. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 270. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 271. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY 2-5 ML, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA PLASTIC BLOOD COLLECTION TUBES MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)